GSK backs campaign for disclosure of trial data

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f819 (Published 7 February 2013)
Cite this as: BMJ 2013;346:f819

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Zosia Kmietowicz
  1. 1BMJ

The UK based pharmaceutical giant GlaxoSmithKline has become the first drug company to sign up to a campaign for all clinical trials to be registered and their full results disclosed.

The AllTrials initiative (alltrials.net) was set up in January by the charity Sense About Science, the BMJ, and other supporters of transparency in research.1 It is calling for registration of all clinical trials and for full study results and full clinical study reports (CSRs) to be made publicly available.

CSRs are formal study reports that provide more details on the design, methods, and results of clinical trials than published papers and …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL